Timing & pharmacokinetics
How long does Saffron take to work?
Onset timing for Saffron varies in the clinical literature. Onset timing is not well-quantified in our dataset, refer to clinical citations on the main entry.
Onset
–
Half-life
–
Duration
–
Timing
AM/midday
Key facts
- typical dose
- 28–30 mg
- dose frequency
- 1-2 doses
- timing
- AM/midday
- with food
- with meal
- safety score
- 4/5
- evidence grade
- A
- class
- adaptogen
- PubMed citations
- 1700
- legal status (US)
- Over-the-counter
- legal status (UK)
- Over-the-counter
- legal status (EU)
- Over-the-counter
- legal status (AU)
- Over-the-counter
- primary mechanism
- Crocin (carotenoid responsible for the red colour) and safranal (volatile compound responsible for the aroma) both inhibit serotonin and dopamine reuptake at neurochemically meaningful concentrations.
Onset window
Saffron onset times in the published literature vary widely. Refer to the citations on the main Saffron entry for compound-specific pharmacokinetic data.
Food effect: Taking with food slows absorption but improves tolerance. Onset shifts 30–60 minutes later than empty-stomach dosing.
Half-life and dosing frequency
Half-life is not characterised in our dataset.
Acute vs. chronic effect
Some nootropics work the first time you take them (Saffron may or may not). Others, adaptogens, racetams, and most botanicals targeting BDNF or NGF pathways, require 2–4 weeks of daily dosing before the full effect emerges.
If you don’t feel anything after a single dose and the compound is in the chronic-effect category, that is normal, extend the trial to 2–4 weeks before evaluating. If it is in the acute category and you feel nothing, consider dose, vendor sourcing, or whether the compound matches your goal.
Protocol note from the Saffron entry
Standardize to ≥0.4% safranal.
Mechanism, safety, and citations for Saffron are on the main reference page, see Saffron. For full dose protocol see Saffron dosage. To check for stack-level pharmacokinetic conflicts, use the interaction checker.
Onset and pharmacokinetic data reflect the published literature for healthy adults at typical doses. Individual variation in absorption, metabolism (CYP genotype), and gut transit can shift onset by ±50%. This page is informational and not medical advice. See our full disclaimer.